Android app on Google Play

Chelsea Therapeutics (CHTP) Reports Q4 Loss of 20c/Share

March 6, 2012 4:21 PM EST Send to a Friend
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) reported Q4 EPS of ($0.20), $0.12 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Chelsea Therapeutics International Ltd. (CHTP) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment